Rankings
▼
Calendar
SAVA Q4 2022 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SAVA
Cassava Sciences, Inc.
$116M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$18M
Operating Income
-$21M
Net Income
-$19M
EPS (Diluted)
$-0.43
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$21M
Stock-Based Comp.
$616,000
Balance Sheet
Total Assets
$235M
Total Liabilities
$7M
Stockholders' Equity
$228M
Cash & Equivalents
$201M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$18M
-$10M
-70.7%
Operating Income
-$21M
-$14M
-45.0%
Net Income
-$19M
-$14M
-35.0%
← FY 2022
All Quarters
Q1 2023 →